XOMA Royalty (XOMA) Return on Assets (2011 - 2026)
XOMA Royalty's (XOMA) quarterly Return on Assets came in at 0.0% in Q1 2026, little changed year-on-year from 0.0% in Q1 2025, and up 26.95% quarter-over-quarter from 0.0% in Q4 2025.
XOMA Royalty (XOMA) Return on Assets (2011 - 2026) Analysis & Trends
XOMA Royalty has disclosed Return on Assets across 16 years of filings, most recently posting 0.0% for Q1 2026.
- Return on Assets for Q1 2026 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
- Return on Assets came in at 0.0% for Q1 2026 at XOMA Royalty, up from 0.0% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.0% in Q1 2022 to a low of 0.0% in Q3 2024.
- The 5-year median for Return on Assets is 0.0% (2022), against an average of 0.0%.
- Peak annual rise in Return on Assets reached 0 bps in 2022, while the deepest fall reached 0 bps in 2022.
- XOMA Royalty's Return on Assets stood at 0.0% in 2022, then plunged by 92 bps to 0.0% in 2023, then surged by 39 bps to 0.0% in 2024, then surged by 79 bps to 0.0% in 2025, then climbed by 27 bps to 0.0% in 2026.
- The last three Return on Assets figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | -0.80% |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -0.01% |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 0.00% |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -0.01% |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 0.00% |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 0.00% |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -0.01% |
| 10 | XOMA Royalty | 5.52 Mn | -60.56 Mn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |